{
  "id": "5a897927fcd1d6a10c00000a",
  "type": "summary",
  "question": "What does A1C measure?",
  "ideal_answer": "Glycated proteins, such as glycated hemoglobin (HbA1c) or glycated albumin (GA) in the blood, are essential indicators of glycemic control for diabetes mellitus. ",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/18030866",
    "http://www.ncbi.nlm.nih.gov/pubmed/21470266",
    "http://www.ncbi.nlm.nih.gov/pubmed/20807443",
    "http://www.ncbi.nlm.nih.gov/pubmed/20861123",
    "http://www.ncbi.nlm.nih.gov/pubmed/28964455",
    "http://www.ncbi.nlm.nih.gov/pubmed/24511995",
    "http://www.ncbi.nlm.nih.gov/pubmed/21737172",
    "http://www.ncbi.nlm.nih.gov/pubmed/22027330",
    "http://www.ncbi.nlm.nih.gov/pubmed/27522349",
    "http://www.ncbi.nlm.nih.gov/pubmed/26630892",
    "http://www.ncbi.nlm.nih.gov/pubmed/20923490",
    "http://www.ncbi.nlm.nih.gov/pubmed/27737895",
    "http://www.ncbi.nlm.nih.gov/pubmed/21920547",
    "http://www.ncbi.nlm.nih.gov/pubmed/15644138"
  ],
  "snippets": [
    {
      "text": "Glycated proteins, such as glycated hemoglobin (HbA1c) or glycated albumin (GA) in the blood, are essential indicators of glycemic control for diabetes mellitus. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/27522349",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": ": Monitoring of glycemic control with hemoglobin A1c(A1c) in hemodialysis patients may be compromised by anemia and erythropoietin therapy.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/27737895",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "<b>BACKGROUND</b>: A1c, a surrogate measure of glycemic control, is known to have a strong linear correlation with mean plasma glucose (MPG) when analyzed in populations of patients.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/20923490",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "BACKGROUND A1c, a surrogate measure of glycemic control, is known to have a strong linear correlation with mean plasma glucose (MPG) when analyzed in populations of patients.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/20923490",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Hemoglobin A1c (HbA1c) has been used by clinicians as a means to measure short to intermediate term glucose control in diabetics. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21920547",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "To estimate the impact of increased glycated hemoglobin (A1C) monitoring and treatment intensification for patients with type 2 diabetes (T2D) on quality measures and reimbursement within the Medicare Advantage Star (MA Star) program.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28964455",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Hemoglobin A1c (A1c) was recently added to the diagnostic criteria for diabetes and prediabetes.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/20861123",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "AIMS: The purpose of this study was to develop a measure of psychosocial barriers to adherence in adolescents with type 1 diabetes (T1D) and examine relationships to patient characteristics, adherence, and hemoglobin A1C (A1C).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21737172",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "To compare the ability of alternative wait time measures to predict glycated hemoglobin (A1C) levels among diabetes patients.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24511995",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Chronic complications of diabetes can be reduced through optimal glycemic and lipid control as evaluated through measurement of glycosylated hemoglobin (A1C) and low-density lipoprotein cholesterol (LDL-C)",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/20807443",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": " The assessment of glycemic control, most commonly using glycosylated hemoglobin (A1C), has been a major measure for care of patients with diabetes. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/18030866",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Glycated haemoglobin, as measured by haemoglobin A1C (A1C), c",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21470266",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Hemoglobin A1c is the measurement of glycated hemoglobin and can aid in both the diagnosis and continued management of diabetes mellitus",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/26630892",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Diabetes treatment trials intended to seek indications for glycemic control are facilitated by the regulatory acceptance of glycosylated hemoglobin (A1C) as a validated intermediate efficacy end point",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22027330",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Hemoglobin A1c (HbA1c or simply A1c) is a measure of a long-term blood plasma glucose average, a reliable index to reflect one's diabetic condition. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/15644138",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": []
}